New Phase 2/3 Clinical Trial for Liver Disease in Alpha-1 Antitrypsin Deficiency Should be Coming Soon

Alpha-1 Antitrypsin Deficiency Alpha-1 Antitrypsin Deficiency (AATD) is a rare disease caused by low levels of the Alpha-1 Antitrysin protein. It can lead to lung disease and liver disease. Liver…

Continue Reading New Phase 2/3 Clinical Trial for Liver Disease in Alpha-1 Antitrypsin Deficiency Should be Coming Soon
Study Indicates Safety of New Potential Treatment for Swallowing Dysfunction in Kennedy Disease
source: pixabay.com

Study Indicates Safety of New Potential Treatment for Swallowing Dysfunction in Kennedy Disease

Kennedy disease or, Spinal and Bulbar Muscular Atrophy (SBMA) is a form of Spinal Muscular Atrophy (SMA). SBMA causes muscle weakness throughout the limbs which results in impaired mobility (typical…

Continue Reading Study Indicates Safety of New Potential Treatment for Swallowing Dysfunction in Kennedy Disease

New Partnership will Improve and Accelerate Patient Involvement in Lung Cancer Research

Pattern.Org Pattern.org was created by the Rare Cancer Research Foundation, a nonprofit dedicated to improving the lives of rare cancer patients by accelerating research. Pattern.org specifically, is a branch of…

Continue Reading New Partnership will Improve and Accelerate Patient Involvement in Lung Cancer Research

New Biosimilar Product to Humira Could Be Cheaper and Just as Effective for Ankylosing Spondylitis Patients

The most common treatment for autoimmune conditions such as ankylosing spondylitis, plaque psoriasis, Crohn's disease, juvenile idiopathic arthritis, and rheumatoid arthritis is currently a drug called Humira, created by AbbVie.…

Continue Reading New Biosimilar Product to Humira Could Be Cheaper and Just as Effective for Ankylosing Spondylitis Patients

A Record Number of FDA Drug Approvals in 2018 Is Followed by an Encouraging Start for 2019

Following a record number of approvals in 2018, the FDA has recently approved two new drugs with many more anticipated approvals later in the year. Trazimera to Treat Human Epidermal…

Continue Reading A Record Number of FDA Drug Approvals in 2018 Is Followed by an Encouraging Start for 2019
The Challenges Faced by Those Affected by PFIC Highlighted on Rare Disease Day
source: pixabay.com

The Challenges Faced by Those Affected by PFIC Highlighted on Rare Disease Day

According to a story from Financial Buzz, the biopharmaceutical company Albireo Pharma, Inc. issued a statement on Rare Disease Day which emphasized the company's continued commitment to progressive familial intrahepatic…

Continue Reading The Challenges Faced by Those Affected by PFIC Highlighted on Rare Disease Day
Actress Kathy Bates Discusses Being Diagnosed With Ovarian Cancer and Breast Cancer…and Surviving
laurixnh / Pixabay

Actress Kathy Bates Discusses Being Diagnosed With Ovarian Cancer and Breast Cancer…and Surviving

According to a story from yahoo.com, actress Kathy Bates realized when she was fairly young that she was at an increased risk for breast cancer. This was because both her…

Continue Reading Actress Kathy Bates Discusses Being Diagnosed With Ovarian Cancer and Breast Cancer…and Surviving

How Changing to Outcome-Based Reimbursement Models is Better for Rare Disease Patients

Shifting Contracts Over the years the United States healthcare system has shifted more toward reimbursement models that are outcome-based instead of service-based. In essence, this means that instead of paying…

Continue Reading How Changing to Outcome-Based Reimbursement Models is Better for Rare Disease Patients
After Diagnosis, a Yale Alum Establishes Nonprofit Focused on Amyotrophic Lateral Sclerosis
12019 / Pixabay

After Diagnosis, a Yale Alum Establishes Nonprofit Focused on Amyotrophic Lateral Sclerosis

According to a story from the Yale Daily News, Brian Wallach, class of 2003, was diagnosed with amyotrophic lateral sclerosis, or Lou Gehrig's disease, in November of 2017. Although being…

Continue Reading After Diagnosis, a Yale Alum Establishes Nonprofit Focused on Amyotrophic Lateral Sclerosis
“Breathe With Me” Song Raising Awareness About Cystic Fibrosis ‘Precision Medicine’ Campaign
Indie Pop Artist Betsa Advocates for CF Patients

“Breathe With Me” Song Raising Awareness About Cystic Fibrosis ‘Precision Medicine’ Campaign

Emerging Indie pop artist Betsa has recorded a song to raise awareness for an important cause – one that has been making national headlines in recent weeks. Her new release…

Continue Reading “Breathe With Me” Song Raising Awareness About Cystic Fibrosis ‘Precision Medicine’ Campaign
Company Receives Award for Developing Breakthrough Neurotrophic Keratitis Treatment
source: pixabay.com

Company Receives Award for Developing Breakthrough Neurotrophic Keratitis Treatment

According to a story from prnewswire.com, the biopharmaceutical company Dompé recently announced that the company has received the 2019 Industry Innovation Award from the National Organization of Rare Disorders (NORD).…

Continue Reading Company Receives Award for Developing Breakthrough Neurotrophic Keratitis Treatment